Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020)
Powered by 
Analysis
Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 19.52% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 4.76% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -22.30% |
| 10 | Nektar Therapeutics | 2.45 Bn | 1.77 Bn | 3.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 27.79% |
| Dec 31, 2019 | 27.35% |
| Sep 30, 2019 | 0.72% |
| Jun 30, 2019 | 0.72% |
| Mar 31, 2019 | 0.72% |
| Dec 31, 2018 | 0.72% |
| Sep 30, 2018 | 25.40% |
| Jun 30, 2018 | 25.33% |
| Mar 31, 2018 | 25.26% |
| Dec 31, 2017 | 25.18% |
| Sep 30, 2017 | 25.11% |
| Jun 30, 2017 | 25.03% |
| Mar 31, 2017 | 24.96% |
| Dec 31, 2016 | 24.88% |
| Sep 30, 2016 | 24.81% |
| Jun 30, 2016 | 24.73% |
| Mar 31, 2016 | 24.66% |
| Dec 31, 2015 | 24.58% |
| Sep 30, 2015 | 0.00% |
| Mar 31, 2015 | -16.53% |